phase readout
saveNCT07300891: T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Refractory Solid Cancer Patients Unexposed to Immunotherapy
view source ↗
comments(0)
5-min edit window · permanent after that